SCI时时刷

search
+
Hematopoietic cell transplantation can be safely performed after COVID-19
Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USAAlejandro Marinos, Jeremy Ramdial, Fareed Khawa...
Acute GVHD classification based on the dynamics of GVHD skin involvement from its appearance to the start of systemic treatment
Acute GVHD classification based on the dynamics of GVHD skin involvement from its appearance to the start of systemic treatment
We conducted a prospective study aimed at investigating the prognostic value of the dynamic of a-GVHD progression from cut...
Randomized phase 2 study of digital life coaching during transplantation for myeloma
Randomized phase 2 study of digital life coaching during transplantation for myeloma
Competing interests CR, AL, SA, and AD: no competing interests. RB: consulting f...
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Competing interests EvH, WK and YvO are employees of Xenikos and own equity in X...
Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China
Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. ...
Understanding and treatment of cutaneous graft-versus-host-disease
Understanding and treatment of cutaneous graft-versus-host-disease
The skin is the outermost mechanical barrier where dynamic immune reactions take place and is the most commonly affected s...
Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia
Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia
Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, et al. Outcome and prognostic factors among patie...
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma
Recently there has been a growing interest in evaluating body composition as a marker for prognosis in cancer patients. Th...
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease
Patients with chronic graft-versus-host disease (cGVHD) are at heightened risk for components of metabolic syndrome (MetS)...
Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States
Competing interests ML, NE, ME, LEP, ANW, JP, WD report no conflicts of interest...
Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
Persistent thrombocytopenia (PT) has an unsatisfactory response to therapy after haploidentical haematopoietic stem cell t...
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Allogeneic hematopoietic cell transplantation (allo-HCT) is curative for myelofibrosis (MF) but assessing risk-benefit in ...
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
Cancer and Blood Disorders Center, Seattle Children’s Hospital, Seattle, WA, USATristan E. KnightDivision of Hematology an...
Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease
Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease
Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, et al. Registry data analysis of hematopoietic stem cell trans...
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
The COVID-19 pandemic has had a significant impact on medical practices, including the delivery of allogeneic hematopoieti...
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic
The authors acknowledge the support of “Centro di Ricerca sulle cellule staminali emopoietiche e le terapie cellulari “Uni...
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
We compared outcomes, of 1609 patients with secondary acute myeloid leukemia (sAML) undergoing allogeneic transplantation ...
Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation
Pulmonary function and long-term survival in patients with PERDS after autologous hematopoietic stem cell transplantation
Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic s...
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
We report the results from a multicentre retrospective study of 220 adult patients who underwent allogeneic hematopoietic ...
Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study
Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study
Psychosocial health predicts and contributes to medical outcomes for patients undergoing hematopoietic stem cell transplan...
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT
In patients with acute myeloid leukemia (AML) of intermediate-risk (IR) in first remission (CR1) with no measurable residu...
Dexamethasone palmitate as an etoposide-free treatment for children with hemophagocytic lymphohistiocytosis after hematopoietic cell transplantation
Sandler RD, Carter S, Kaur H, Francis S, Tattersall RS, Snowden JA. Haemophagocytic lymphohistiocytosis (HLH) following al...
Understanding risks and refining strategies for thromboembolism prophylaxis in hematopoietic stem cell transplant recipients
The topic of thromboembolic (TE) risks in hematopoietic stem cell transplant (HSCT) recipients is relativ...
Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas
Hutchings M, Morschhauser F, Iacoboni G, Carlo-Stella C, Offner FC, Sureda A, et al. Glofitamab, a Novel, Bivalent CD20-Ta...
Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients
Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients
Hematopoietic cell transplant (HCT) recipients are at risk for thromboembolic and bleeding complications. There is limited...
Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT
Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT
El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, et al. Impact of pre-transplant depression on outcomes of al...
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
There is only limited data on cytomegalovirus (CMV) prophylaxis with high-dose (HD) aciclovir after allogeneic hematopoiet...
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation
The HCT Frailty Scale is an easy prognostic tool composed of (a) Clinical Frailty Scale; (b) Instrumental Activities of Da...
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study
Rheumatic autoimmune diseases not only involve the production of autoantibodies but also demonstrate T-cell dysfunction. I...
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation
Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hem...
阅读更多
format_indent_increase